L&C Bio Obtains Patent Related to ZAG-Derived Peptides
[Asia Economy Reporter Baek Kyunghwan] L&C Bio announced on the 24th that it has acquired a patent related to ZAG protein-derived peptides. The company explained, "This patent proves that ZAG protein-derived peptides can significantly reduce the levels of inflammatory cytokines and histamine in cells that trigger various immune and inflammatory responses, according to the Ministry of Food and Drug Safety's atopic dermatitis efficacy evaluation guidelines."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- No Cure in Sight... '105 Deaths' Spark Fears as American Also Infected
- "It's Only May, but Convenience Stores Know... Iced Americano at 24°C, Tube Ice Cream at 31°C: The Thermometer of the Summer Sales Boom"
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- [Breaking] Chung Yongjin Apologizes for Starbucks 'Tank Day' Controversy: "I Take Full Responsibility"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
